Humana shares jump 5% as Ambea acquisition clears regulatory hurdle

Ambea received all necessary regulatory approvals for its acquisition of Humana, removing a key uncertainty. The 5% share price rise reflects market relief that the deal will proceed. This is a company-specific event with limited macro impact.